Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings

BMC Complementary and Alternative Medicine

Volumn 14, Issue 1, 2014, Pages

  Arentz, Susan ^a   Abbott, Jason Anthony ^b   Smith, Caroline Anne ^a   Bensoussan, Alan ^a  

^a WESTERN SYDNEY UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CIMICIFUGA RACEMOSA EXTRACT; CINNAMOMUM CASSIA EXTRACT; CLOMIFENE CITRATE; GLYCYRRHIZA EXTRACT; INSULIN; LUTEINIZING HORMONE; PAEONIA LACTIFLORA EXTRACT; PLACEBO; PROLACTIN; SPIRONOLACTONE; TESTOSTERONE; TRIBULUS TERRESTRIS EXTRACT; VITEX AGNUS CASTUS EXTRACT; PLANT EXTRACT;

ABSENCE OF SIDE EFFECTS; AMENORRHEA; ARTICLE; DIET RESTRICTION; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FEMALE; FEMALE FERTILITY; HERBAL MEDICINE; HUMAN; HYPERANDROGENISM; HYPERPROLACTINEMIA; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MEDICAL RESEARCH; NAUSEA AND VOMITING; NONHUMAN; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; PHYTOTHERAPY; POLYCYSTIC OVARY SYNDROME;

AMENORRHEA; FEMALE; HUMANS; HYPERANDROGENISM; OLIGOMENORRHEA; PHYTOTHERAPY; PLANT EXTRACTS; POLYCYSTIC OVARY SYNDROME;

EID: 84938568687     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-511     Document Type: Article

References (110)

1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ: The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010,25(2):544-551.10.1093/humrep/dep399
2. Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, Norman RJ, Costello MF, Guideline Development Groups: Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011,195(6):65.10.5694/mja11.10915
3. ESHRE: Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 2012,27(1):14-24.
4. Messinis IE: Ovulation induction: a mini review. Hum Reprod 2005,20(10):2688-2697.10.1093/humrep/dei128
5. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH: Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010, 1: 2-12.
6. Sills ES, Perloe M, Tucker MJ, Kaplan CR, Genton MG, Schattman GL: Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports. BMC Womens Health 2001,1(1):3.10.1186/1472-6874-1-3
7. Holden S, Davis R, Yeh G: Pregnant Women's Use of Complementary & Alternative Medicine in the United States. J Alternative Compl Med 2014,20(5):A120.
8. Lunny CA, Fraser SN: The Use of Complementary and Alternative Medicines Among a Sample of Canadian Menopausal-Aged Women. J Midwifery Womens Health 2010,55(4):335-343.10.1016/j.jmwh.2009.10.015
9. Bishop JL, Northstone K, Green JR, Thompson EA: The use of complementary and alternative medicine in pregnancy: data from the Avon Longitudinal Study of Parents and Children (ALSPAC). Complement Ther Med 2011,19(6):303-310.10.1016/j.ctim.2011.08.005
10. Nordeng H, Bayne K, Havnen GC, Paulsen BS: Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcome. Complement Ther Clin Pract 2011,17(3):147-151.10.1016/j.ctcp.2010.09.002
11. Smith CA, Bateson DJ, Weisberg E: A survey describing the use of complementary therapies and medicines by women attending a family planning clinic. BMC Complement Altern Med 2013,13(1):224.10.1186/1472-6882-13-224
12. Stankiewicz M, Smith C, Alvino H, Norman R: The use of complementary medicine and therapies by patients attending a reproductive medicine unit in South Australia: a prospective survey. Aust New Zeal J Obstet Gynaecol 2007,47(2):145-149.10.1111/j.1479-828X.2007.00702.x
13. Ren MQ, Kuhn G, Wegner J, Chen J: Isoflavones, substances with multi-biological and clinical properties. Eur J Nutr 2001,40(4):135-146.10.1007/PL00007388
14. Whitten PL, Naftolin F: Reproductive actions of phytoestrogens. Baillieres Clin Endocrinol Metab 1998,12(4):667-690.10.1016/S0950-351X(98)80010-4
15. Wolff MS, Teitelbaum SL, Pinney SM, Windham G, Liao L, Biro F, Kushi LH, Erdmann C, Hiatt RA, Rybak ME, Calafat AM: Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ Health Perspect 2010,118(7):1039-1046.10.1289/ehp.0901690
16. Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H, Ma Y, Zhang Y, Zhang H, Guan Y: A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol 2012,166(1):99-105.10.1530/EJE-11-0616
17. Francis G, Kerem Z, Makkar HPS, Becker K: The biological action of saponins in animal systems: a review. Br J Nutr 2002,88(6):587-605.10.1079/BJN2002725
18. Grant P, Ramasamy S: An Update on Plant Derived Anti-Androgens. Int J Endocrinol Metabol 2012,2012(2, Spring):497-502.
19. Norman RJ, Dewailly D, Legro RS, Hickey TE: Polycystic ovary syndrome. Lancet 2007,370(9588):685-697.10.1016/S0140-6736(07)61345-2
20. ESHRE: Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008,23(3):462-477.
21. Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E: Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev 2009. doi:10.1002/14651858.CD002249.pub4
22. Polson D, Kiddy DS, Mason HD, Franks S: Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders. Fertil Steril 1989,51(1):30-34.
23. Kousta E, White D, Franks S: Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997,3(4):359-365.10.1093/humupd/3.4.359
24. Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH: Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod 2006,21(1):80-89.
25. Williamson E: Synergy and other interactions in phytomedicines. Phytomedicine 2001,8(5):401-409.10.1078/0944-7113-00060
26. Mills S, Bone K: Principles and Practice of Phytotherapy. London, England: Churchill Livingstone Harcourt Publishers; 2000.
27. Wardle JL, Adams J, Lui C-W: A qualitative study of naturopathy in rural practice: A focus upon naturopaths' experiences and perceptions of rural patients and demands for their services. BMC Health Serv Res 2010,10(1):185.10.1186/1472-6963-10-185
28. Steel A, Wardle J, Diezel H, Johnstone K, Adams J: Educating for collaboration: The outcomes of an interprofessional education workshop for complementary and alternative maternity care providers. Adv Integr Med 2014,1(1):17-24.10.1016/j.aimed.2013.05.001
29. Teede H, Gibson-Helm M, Norman RJ, Boyle J: Polycystic Ovary Syndrome: Perceptions and Attitudes of Women and Primary Health Care Physicians on Features of PCOS and Renaming the Syndrome. J Clin Endocrinol Metabol 2013,99(1):E107-E111.
30. ESHRE: Revised 2003 consensus on diagnostic criteria and long-term health risks associated with polycystic ovary syndrome. Fertil Steril 2004,81(1):19-25.
31. Legro RS, Zaino RJ, Demers LM, Kunselman AR, Gnatuk CL, Williams NI, Dodson WC: The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol 2007,196(4):402.e1-402.e11.
32. Conway G, Honour J, Jacobs H: Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989,30(4):459-470.10.1111/j.1365-2265.1989.tb00446.x
33. Balen AH, Tan SL, Jacobs HS: Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. BJOG 1993,100(12):1082-1089.10.1111/j.1471-0528.1993.tb15170.x
34. Legro RS, Kunselman AR, Dodson WC, Dunaif A: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metabol 1999,84(1):165-169.
35. Luciano A, Chapler F, Sherman B: Hyperprolactinemia in polycystic ovary syndrome. Fertil Steril 1984,41(5):719-725.
36. Jarry H, Spengler B, Porzel A, Schmidt J, Wuttke W, Christoffel V: Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones. Planta Med 2003,69(10):945-946.
37. Jarry H, Harnischfeger G, Düker E: Studies on the endocrine effects of the contents of Cimicifuga racemosa. In vitro binding of compounds to estrogen receptors. Planta Med 1985,51(4):316.10.1055/s-2007-969500
38. Jarry H, Spengler B, Wuttke W, Christoffel V: In vitro assays for bioactivity-guided isolation of endocrine active compounds in Vitex agnus-castus. Maturitas 2006, 55: S26-S36.
39. Jarry H, Leonhardt S, Gorkow C, Wuttke W: In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol Diabetes 2009,102(06):448-454.
40. Meier B, Berger D, Hoberg E, Sticher O, Schaffner W: Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine 2000,7(5):373-381.10.1016/S0944-7113(00)80058-6
41. Sliutz G, Speiser P, Schultz AM, Spona J, Zeillinger R: Agnus-castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res 1993,25(5):253-255.10.1055/s-2007-1002090
42. Sun WS, Imai A, Tagami K, Sugiyama M, Furui T, Tamaya T: In vitro stimulation of granulosa cells by a combination of different active ingredients of unkei-to. Am J Chin Med 2004,32(4):569-578.10.1142/S0192415X0400220X
43. Wuttke W, Jarry H, Christoffel V, Spengler B, Seidlová-Wuttke D: Chaste tree (Vitex agnus-castus). Pharmacology and clinical indications. Phytomedicine 2003,10(4):348-357.10.1078/094471103322004866
44. Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer G: Antiestrogenic activities of Cimicifuga racemosa extracts. J Steroid Biochem Mol Biol 2002,80(1):125-130.10.1016/S0960-0760(01)00178-9
45. Düker EM, Kopanski L, Jarry H, Wuttke W: Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 1991,57(5):420-424.10.1055/s-2006-960139
46. Dehghan A, Esfandiari A, Bigdeli SM: Alternative Treatment of Ovarian Cysts with Tribulus terrestris Extract: A Rat Model. Reprod Domest Anim 2012,47(1):e12-e15.10.1111/j.1439-0531.2011.01877.x
47. Esfandiari A, Dehghan A, Sharifi S, Najafi B, Vesali E: Effect of Tribulus terrestris extract on ovarian activity in immature Wistar rat: a histological evaluation. J Anim Vet Adv 2011,10(7):883-886.
48. Heibashy M, Mazen G, Shahin M: Metabolic Changes and Hormonal Disturbances in Polycystic Ovarian Syndrome Rats and the Amelioration Effects of Metformin and/or Cinnamon Extraction. J Am Sci 2013,9(12):p54-p62.
49. Ibrahim N, Shalaby AS, Farag RS, Elbaroty GS, Nofal SM, Hassan EM: Gynecological efficacy and chemical investigation of Vitex agnus-castus L. fruits growing in Egypt. Nat Prod Res 2008,22(6):537-546.10.1080/14786410701592612
50. Lee JC, Pak SC, Lee SH, Lim SC, Bai YH, Jin CS, Kim JS, Na CS, Bae CS, Oh KS: The effect of herbal medicine on nerve growth factor in estradiol valerate-induced polycystic ovaries in rats. Am J Chin Med 2003,31(06):885-895.10.1142/S0192415X03001636
51. Martino-Andrade AJ, Morais RN, Spercoski KM, Rossi SC, Vechi MF, Golin M, Lombardi NF, Greca CS, Dalsenter PR: Effects of Tribulus terrestris on endocrine sensitive organs in male and female Wistar rats. J Ethnopharmacol 2010,127(1):165-170.10.1016/j.jep.2009.09.031
52. Seidlova-Wuttke D, Hesse O, Jarry H, Christoffel V, Spengler B, Becker T, Wuttke W: Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur J Endocrinol 2003,149(4):351-362.10.1530/eje.0.1490351
53. Takeuchi T, Nishii O, Okamura T, Yaginuma T: Effect of traditional herbal medicine, shakuyaku-kanzo-to on total and free serum testosterone levels. Am J Chin Med 1989,17(1-2):35-44.
54. Armanini D, Castello R, Scaroni C, Bonanni G, Faccini G, Pellati D, Bertoldo A, Fiore C, Moghetti P: Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur J Obstet Gynecol Reprod Biol 2007,131(1):61-67.10.1016/j.ejogrb.2006.10.013
55. Armanini D, Mattarello MJ, Fiore C, Bonanni G, Scaroni C, Sartorato P, Palermo M: Licorice reduces serum testosterone in healthy women. Steroids 2004,69(11-12):763-766.
56. Milanov S, Maleeva A, Tashkov M: Tribestan effect on the concentration of some hormones in the serum of healthy subjects. Sofia, Bulgaria: Company documentation, Chemical Pharmaceutical Research Institute; 1981.
57. Ushiroyama T, Ikeda A, Sakai M, Hosotani T, Suzuki Y, Tsubokura S, Ueki M: Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion. J Reprod Med 2001,46(5):451-456.
58. Yaginuma TI, Yasui R, Arai H, Kawabata T: Effect of traditional herbal medicine on serum testosterone levels and its induction of regular ovulation in hyperandrogenic and oligomenorrheic women. Nippon Sanka Fujinka Gakkai Zasshi 1982,34(7):939.
59. Takahashi K, Kitao M: Effect of TJ-68 (shakuyaku-kanzo-to) on polycystic ovarian disease. Int J Fertil Menopausal Stud 1994,39(2):69.
60. Tabakova P, Dimitrov M, Tashkov B: Clinical studies on the preparation Tribestan in women with endocrine infertility or menopausal syndrome. Sofia, Bulgaria: 1st Obstetrical and Gynecological Hospital; 1984.
61. Gerhard I, Patek A, Monga B, Blank A, Gorkow C: Mastodynon® for Female Infertility. Randomized placebo controlled, clinical double-blind study. Forschende Komplementärmedizin/Res Compl Med 1998,5(6):272-278.
62. Bergmann J, Luft B, Boehmann S, Runnebaum B, Gerhard I: The efficacy of the complex medication Phyto-Hypophyson L in female, hormone-related sterility. A randomized, placebo-controlled clinical double-blind study. Forschende Komplementärmedizin und klassische Naturheilkunde. Res Compl Nat Classical Med 2000,7(4):190.
63. Kilicdag E, Tarim E, Bagis T, Erkanli S, Aslan E, Ozsahin K, Kuscu E: Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gynecol Obstet 2004,85(3):292-293.10.1016/j.ijgo.2004.01.001
64. Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T, Schmitz H: Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittel-Forschung (Drug Res) 1993,64(7):752-756.
65. Shahin AY, Ismail AM, Zahran KM, Makhlouf AM: Adding phytoestrogens to clomiphene induction in unexplained infertility patients - a randomized trial. Reprod Biomed Online 2008,16(4):580-588.10.1016/S1472-6483(10)60465-8
66. Wang JG, Anderson RA, Graham GM III, Chu MC, Sauer MV, Guarnaccia MM, Lobo RA: The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril 2007,88(1):240-243.10.1016/j.fertnstert.2006.11.082
67. Kamel HH: Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2013,168(1):60-63.10.1016/j.ejogrb.2012.12.025
68. Shahin AY, Mohammed SA: Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates-a randomized trial. Gynecol Endocrinol 2014,30(7):505-510.10.3109/09513590.2014.895983
69. Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W: In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 2003,44(Supplement 1):S31-S38.
70. Webster D, Lu J, Chen SN, Farnsworth NR, Wang ZJ: Activation of the μ-opiate receptor by Vitex agnus-castus methanol extracts: Implication for its use in PMS. J Ethnopharmacol 2006,106(2):216-221.10.1016/j.jep.2005.12.025
71. Chan CC, Koo MW, Ng EH, Tang OS, Yeung WS, Ho PC: Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome-a randomized placebo-controlled trial. J Soc Gynecol Investig 2006,13(1):63-68.10.1016/j.jsgi.2005.10.006
72. Kao Y-H, Hiipakka RA, Liao S: Modulation of endocrine systems and food intake by green tea epigallocatechin gallate 1. Endocrinology 2000,141(3):980-987.
73. Akdoğan M, Tamer MN, Cüre E, Cüre MC, Köroğlu BK, Delibaş N: Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism. Phytother Res 2007,21(5):444-447.10.1002/ptr.2074
74. Grant P: Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytother Res 2010,24(2):186-188.
75. Kudolo GB, Wang W, Javors M, Blodgett J: The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects-A double blind placebo-controlled, crossover study. Clin Nutr 2006,25(4):606-616.10.1016/j.clnu.2005.12.012
76. Chen J-T, Tominaga K, Sato Y, Anzai H, Matsuoka R: Maitake mushroom (Grifola frondosa) extract induces ovulation in patients with polycystic ovary syndrome: a possible monotherapy and a combination therapy after failure with first-line clomiphene citrate. J Alternative Compl Med 2010,16(12):1295-1299.10.1089/acm.2009.0696
77. Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer MS: Effect of flax seed ingestion on the menstrual cycle. (J Clin Endocrinol Metabo 1993,77(5):1215-1219.
78. Lampe J, Martini MC, Kurzer MS, Adlercreutz H, Slavin JL: Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 1994,60(1):122-128.
79. Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL: Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer 2001,39(1):58-65.10.1207/S15327914nc391_8
80. Frische EJ, Hutchins AM, Martini MC, Thomas W, Slavin JL: Effect of flaxseed and wheat bran on serum hormones and lignan excretion in premenopausal women. J Am Coll Nutr 2003,22(6):550-554.10.1080/07315724.2003.10719335
81. Melo E, Bertero EB, Rios LA, Mattos D Jr: Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trial. Int Braz J Urol 2002,28(5):418-425.
82. Yang J, Te AE: Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 2005,6(4):290-295.10.1007/s11934-005-0026-1
83. Morgia G, Mucciardi G, Madonia M, Castelli T, Favilla V, Magno C: Treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) with Serenoa repens plus selenio and licopene (Profluss®): a randomized multicenter placebo-controlled study. J Urol 2008,179(4):32.
84. Casner PR, Bent S, Kane C, Shinohara K: Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006,354(18):1950-1951.
85. Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M: The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 2006,20(12):1036-1039.10.1002/ptr.1988
86. Jalilian N, Modarresi M, Rezaie M, Ghaderi L, Bozorgmanesh M: Phytotherapeutic Management of Polycystic Ovary Syndrome: Role of Aerial Parts of Wood Betony (Stachys lavandulifolia). Phytother Res 2013,27(11):1708-1713.10.1002/ptr.4921
87. Najafipour F, Rahimi AO, Mobaseri M, Agamohamadzadeh N, Nikoo A, Aliasgharzadeh A: Therapeutic effects of stinging nettle (Urtica dioica) in women with Hyperandrogenism. Int J Current Res Acad Rev 2014,2(7):153-160.
88. Hryb D, Khan MS, Romas NA, Rosner W: The effect of extracts of the roots of the stinging nettle. Planta Med 1995,61(01):31-32.10.1055/s-2006-957993
89. Schöttner M, Ganßer D, Spiteller G: Lignans from the Roots of Urtica spp. Planta Med 1997,63(06):529-532.10.1055/s-2006-957756
90. Zhang Q, Li L, Liu L, Li Y, Yuan L, Song L, Wu Z: Effects of the polysaccharide fraction of Urtica fissa on castrated rat prostate hyperplasia induced by testosterone propionate. Phytomedicine 2008,15(9):722-727.10.1016/j.phymed.2007.12.005
91. Hajhashemi V, Klooshani V: Antinociceptive and anti-inflammatory effects of Urtica dioica leaf extract in animal models. Avicenna J Phytomedicine 2013,3(2):193-200.
92. Loch E, Böhnert K, Peeters M: The treatment of menstrual disorders with Vitex agnus-castus tincture. Der Frauenarzt 1991,32(8):867-870.
93. Loch E, Selle H, Boblitz N: Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med 2000,9(3):315-320.10.1089/152460900318515
94. Ma L, Lin S, Chen R, Zhang Y, Chen F, Wang X: Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust New Zeal J Obstet Gynaecol 2010,50(2):189-193.10.1111/j.1479-828X.2010.01137.x
95. Schellenberg R: Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ (Clin Res ed) 2001, 134-137.
96. Lauritzen CH, Reuter HD, Repges R, Böhnert KJ, Schmidt U: Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxine. Phytomedicine 1997,4(3):183-189.10.1016/S0944-7113(97)80066-9
97. He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, Yao Y, Lu J, Lin S: Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China. Maturitas 2009,63(1):99-103.10.1016/j.maturitas.2009.01.006
98. Wuttke W, Splitt G, Gorkow C, Sieder C: Treatment of cyclical mastalgia: Results of a randomised, placebo- controlled, double-blind study: Objective. Obstet Gynecol 1997,57(10):569-574.
99. Halaska M, Beles P, Gorkow C, Sieder C: Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. Breast 1999,8(4):175-181.10.1054/brst.1999.0039
100. Wuttke W, Seidlova-Wuttke D, Gorkow C: The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003, 44: S67-S77.
101. Yamada K, Kanba S, Yagi G, Asai M: Herbal medicine (Shakuyaku-kanzo-to) in the treatment of risperidone-induced amenorrhea. J Clin Psychopharmacol 1999,19(4):380.10.1097/00004714-199908000-00018
102. Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang HK, Itokawa H, Su CY, Shih C, Chiang T, Chang E: Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. J Med Chem 2002,45(23):5037-5042.10.1021/jm020200g
103. Zangeneh FZ, Minaee B, Amirzargar A, Ahangarpour A, Mousavizadeh K: Effects of chamomile extract on biochemical and clinical parameters in a rat model of polycystic ovary syndrome. J Reprod Infertil 2010,11(3):169.
104. Akdogan M, Ozguner M, Kocak A, Oncu M, Cicek E: Effects of peppermint teas on plasma testosterone, follicle-stimulating hormone, and luteinizing hormone levels and testicular tissue in rats. Urology 2004,64(2):394-398.10.1016/j.urology.2004.03.046
105. Gebhardt R: Antioxidative, antiproliferative and biochemical effects in HepG2 cells of a homeopathic remedy and its constituent plant tinctures tested separately or in combination. Arzneimittel Forschung 2003,53(12):823-830.
106. Burdette JE, Liu J, Chen S, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, van Breemen RB, Farnsworth NR: Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003,51(19):5661-5670.10.1021/jf034264r
107. Whitehead SA, Lacey M: Phytoestrogens inhibit aromatase but not 17β hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa luteal cells: evidence for FSH induction of 17β HSD. Hum Reprod 2003,18(3):487-494.10.1093/humrep/deg125
108. Zhao L, Li W, Han F, Hou L, Baillargeon J-P, Kuang H, Wang Y, Wu X: Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertil Steril 2011,95(1):461-463.10.1016/j.fertnstert.2010.07.1090
109. Kostova I, Dinchev D: Saponins in Tribulus terrestris - Chemistry and bioactivity. Phytochem Rev 2005,4(2-3):111-137.
110. Takeuchi T, Nishii O, Okamura T, Yaginuma T: Effect of paeoniflorin, glycyrrhizin and glycyrrhetic acid on ovarian androgen production. Am J Chin Med 1991,19(1):73-78.10.1142/S0192415X91000119